Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

PDSB stock hub

PDS Biotechnology Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PDSBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

69.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

PDSB

In the news

Latest news · PDSB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-244.2

P25 -106.6P50 -46.9P75 -3.1

ROIC-58.8

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PDSB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

180

Groups with data

Currency

USD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001472091
Company name	PDS Biotechnology Corporation
Country	United States
Country code	US
Cusip	70465T107
Employees	24
Employees Change	-1%
Employees Change Percent	-4
Enterprise value	$60M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US70465T1079
Last refreshed	2026-05-10
Market cap	$69.8M
Market cap category	Micro-Cap
Price	$1.25
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	PDSB
Website	https://www.pdsbiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-49.44%
FCF yield	-39.78%
P/B ratio	7.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-34.5M
Net Income Growth Quarters	2%
Net Income Growth Years	2%
Profit Per Employee	$-1.4M
ROA	-51.98
Roa5y	-39.64
ROCE	-150.1
ROE	-244.2
Roe5y	-129.4
ROIC	-58.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	7.77%
Cagr3y	-42.36%
Cagr5y	-23.72%
EPS Growth Quarters	9
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$30.5M
Cash	$26.7M
Current Assets	$28.3M
Current Liabilities	$9.5M
Debt	$16.9M
Debt Equity	$1.83
Equity	$9.3M
Interest Coverage	-5.91
Liabilities	$21.2M
Long Term Assets	$2.2M
Long Term Liabilities	$11.8M
Net Cash	$9.8M
Net Cash By Market Cap	$14.03
Net Cash Growth	-50.73%
Net Debt Equity	$-1.06
Tangible Book Value	$9.3M
Tangible Book Value Per Share	$0.17
WACC	14.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.98
Net Working Capital	$-2.8M
Quick ratio	2.82
Working Capital	$18.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-27.25%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	7.76%
200-day SMA	0.94
3Y total return	-80.86%
50-day SMA	0.86
50-day SMA vs 200-day SMA	50under200
5Y total return	-74.17%
All Time High	17.85
All Time High Change	-93%
All Time High Date	2021-09-24
All Time Low	0.51
All Time Low Change	146.65%
All Time Low Date	2026-03-31
ATR	0.13
Beta	1.5
Beta1y	3.35
Beta2y	2.88
Ch YTD	62.38
High	1.29
High52	1.92
High52 Date	2025-06-11
High52ch	-34.73%
Low	1.14
Low52	0.51
Low52 Date	2026-03-31
Low52ch	146.65%
Ma50ch	45.28%
Premarket Change Percent	2.56
Premarket Price	$1.17
Premarket Volume	14,054
Price vs 200-day SMA	33.3%
RSI	63.59
RSI Monthly	42.81
RSI Weekly	59.1
Sharpe ratio	0.49x
Sortino ratio	0.85
Total Return	-27.25%
Tr YTD	62.38
Tr1m	36.17%
Tr1w	27.46%
Tr3m	74.83%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.14
Operating Income	$-31.5M
Price target	$9
Price Target Change	$620

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	51,569,756%
Float Percent	92.39%
Net Borrowing	-7,562,991
Shares Insiders	2.53%
Shares Institutions	9.4%
Shares Out	55,815,653
Shares Qo Q	10.07%
Shares Yo Y	27.25%
Short Float	3.33%
Short Ratio	1.7
Short Shares	3.08

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-31.9M
Average Volume	981,331.2x
Bv Per Share	0.17
Ch1m	36.17
Ch1w	27.46
Ch1y	7.76
Ch3m	74.83
Ch3y	-80.86
Ch5y	-74.17
Ch6m	37.27
Change	9.65%
Change From Open	7.76
Close	1.14
Days Gap	1.75
Depreciation Amortization	60,518
Dollar Volume	1,141,150
Earnings Date	2026-05-13
Earnings Time	bmo
EBIT	$-31.5M
EBITDA	$-31.5M
EPS	$-0.74
F Score	2
FCF	$-27.8M
FCF EV Yield	-46.27x
FCF Per Share	$-0.5
Financing CF	12,774,390
Fiscal Year End	December
Founded	2,005
Income Tax	$-1.2M
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Last Split Date	2019-03-18
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	0.87
Ma150ch	44.29%
Ma20	1.11
Ma20ch	12.21%
Net CF	-14,977,622
Next Earnings Date	2026-05-13
Open	1.16
Optionable	Yes
Position In Range	73.33
Post Close	1.25
Postmarket Change Percent	0.8
Postmarket Price	$1.26
Ppne	243,698
Pre Close	1.14
Price Date	2026-05-08
Ptbv Ratio	7.54
Relative Volume	0.93x
Share Based Comp	4,106,606
Tr6m	37.27%
Us State	New Jersey
Volume	912,920

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PDSB pay a dividend?

Capital-return profile for this ticker.

Performance

PDSB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PDSB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.4%

Float: +92.4% of shares outstanding

Insider ownership

+2.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PDSB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.6

Neutral momentum band

Price vs 200-day MA

+33.3%

50/200-day relationship not available

Beta (5Y)

1.50

More volatile than the market

Sharpe ratio

0.49

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PDSB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PDSB stock rating?

PDS Biotechnology Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PDSB analysis?

The full report lives at /stocks/PDSB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PDSB?

The latest report frames PDSB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PDSB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.